Ultragenyx Pharmaceutical (RARE) Q1 2021 Earnings

11FebConfirmed
Q2 2020
Q3 2020
Q4 2020
Q1 2021
-1.91
-1.14
-0.36
0.41

Details

Expected EPS
-1.12
Actual EPS
-0.37
Surprise EPS
0.75
Surprise Percent
+66.96%

Description

Ultragenyx Pharmaceutical (RARE) has reported earnings of -0.37 per share for Q1 2021.

0 Comments

Share your thoughts